Rivaroxaban and Risk of Venous Thromboembolism in Patients With Symptomatic Peripheral Artery Disease After Lower Extremity Revascularization
23/06/2022
אין תגובות
Connie N. Hess, MD, MHS1,2; Michael Szarek, PhD2,3; Sonia S. Anand, MD4; et alRupert M. Bauersachs, MD5; Manesh R. Patel, MD6; E. Sebastian Debus, MD, PhD7; Mark R. Nehler, MD2,8; Warren H. Capell, MD2,9; Joshua A. Beckman, MD10; Gregory Piazza, MD, MS11; Stanislav Henkin, MD, MPH12; Alessandra Bura-Rivière, MD, PhD13; Holger Lawall, MD14; Karel Roztocil, MD, PhD15; Judith Hsia, MD1,2; Eva Muehlhofer, MD16; Scott D. Berkowitz, MD1,2,17; Lloyd P. Haskell, MD18; Marc P. Bonaca, MD, MPH1,2 Author Affiliations Article Information JAMA Netw
